Distalmotion has raised $90 million in Series E financing to support the global commercialization of its surgical robot Dexter.
Revival Healthcare Capital led the round with participation from 415 Capital, as well as existing investors.
CE-marked Dexter shifts the paradigm of robotic surgery by bringing the surgeon back into the sterile field, allowing direct patient access at all times and integrating proven laparoscopic workflows into the robotic setup. [Read more…] about Distalmotion raises $90 million to accelerate adoption of its surgical robot
